QTc prolongation and drugs - Reply

被引：0
|
作者：
Abernethy, DR [1 ]
机构：
[1] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 70卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：568 / 568
页数：1
相关论文
共 50 条
  • [1] QTc prolongation and drugs
    Henderson, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (06) : 567 - 568
  • [2] Galantamine and QTc prolongation - Reply
    Nelson, Matthew W.
    Buchanan, Robert W.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (01) : 169 - 170
  • [3] Methadone and QTc prolongation - Reply
    Mehler, Philip
    Krantz, Mori
    LANCET, 2007, 369 (9559): : 366 - 367
  • [4] Psychotropic drugs associated with QTc prolongation
    van Noord, Charlotte
    Straus, Sabine M. J. M.
    Sturkenboom, Miriam C. J. M.
    Witteman, Jacqueline C. M.
    Stricker, Bruno H. Ch
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S124 - S124
  • [5] Prolongation of QTc interval and antipsychotics - Reply
    Glassman, AH
    Bigger, JT
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06): : 1064 - 1064
  • [6] In reply. QTc prolongation and delamanid: access and safety
    Furin, Jennifer
    Harausz, Elizabeth
    Zimetbaum, Peter
    Cox, Helen
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (10) : 1262 - 1263
  • [7] QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
    Wenzel-Seifert, Katharina
    Wittmann, Markus
    Haen, Ekkehard
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (41): : 687 - U11
  • [8] Role of modeling and simulation in evaluating the QTc prolongation potential of drugs
    Rohatagi, Shashank
    Song, S.
    Sarapa, N.
    Khariton, T.
    Carrothers, T.
    Kuwabara-Wagg, J.
    Kastrissios, H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1189 - 1189
  • [9] Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs
    Rohatagi, Shashank
    Carrothers, Timothy J.
    Kuwabara-Wagg, Jon
    Khariton, Tatiana
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (11): : 1284 - 1296
  • [10] Association of Cardiovascular Drugs and NOS1AP with QTc Prolongation
    van Noord, C.
    Aarnoudse, A.
    Sturkenboom, M.
    Straus, S.
    Witteman, J.
    Stricker, B.
    DRUG SAFETY, 2008, 31 (10) : 901 - 901
12345